Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling
Open Access
- 21 June 2024
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (6) , 1-13
Abstract
Colorectal cancer (CRC) remains a major global cause of cancer-related mortality, lacking effective biomarkers and therapeutic targets. Revealing the critical pathogenic factors of CRC and the underlying mechanisms would offer potential therapeutic strategies for clinical application. G protein signaling (RGS) protein family modulators play essential role within regulating downstream signaling of GPCR receptors, with function in cancers unclear. Our study focused on the expression patterns of RGS proteins in CRC, identifying Regulator of G protein signaling 16 (RGS16) as a prospective diagnostic and therapeutic target. Analyzing 899 CRC tissues revealed elevated RGS16 levels, correlating with clinicopathological features and CRC prognosis by immunohistochemistry (IHC) combined with microarray. We confirmed the elevated RGS16 protein level in CRC, and found that patients with RGS16-high tumors exhibited decreased disease-specific survival (DSS) and disease-free survival (DFS) compared to those with low RGS16 expression. Functional assays demonstrated that RGS16 promoted the CRC progression, knockdown of RGS16 led to significantly increased apoptosis rates of CRC in vitro and in vivo. Notably, we also confirmed these phenotypes of RGS16 in organoids originated from resected primary human CRC tissues. Mechanistically, RGS16 restrained JNK/P38-mediated apoptosis in CRC cells through disrupting the recruitment of TAB2/TAK1 to TRAF6. This study provides insights into addressing the challenges posed by CRC, offering avenues for clinical translation.Keywords
Funding Information
- National Natural Science Foundation of China (82272705)
This publication has 47 references indexed in Scilit:
- RGS16 Is a Marker for Prognosis in Colorectal CancerAnnals of Surgical Oncology, 2009
- Signal integration by JNK and p38 MAPK pathways in cancer developmentNature Reviews Cancer, 2009
- Non-Smad pathways in TGF-β signalingCell Research, 2008
- The retinoid anticancer signal: mechanisms of target gene regulationBritish Journal of Cancer, 2005
- TAB2 and TAB3 Activate the NF-κB Pathway through Binding to Polyubiquitin ChainsMolecular Cell, 2004
- TAB2, a Novel Adaptor Protein, Mediates Activation of TAK1 MAPKKK by Linking TAK1 to TRAF6 in the IL-1 Signal Transduction PathwayMolecular Cell, 2000
- The p53 tumor suppressor targets a novel regulator of G protein signalingProceedings of the National Academy of Sciences, 1997
- Structure of RGS4 Bound to AlF4−-Activated Giα1: Stabilization of the Transition State for GTP HydrolysisCell, 1997
- A new family of G-protein regulators — the RGS proteinsCurrent Opinion in Cell Biology, 1997
- RGS family members: GTPase-activating proteins for heterotrimeric G-protein α-subunitsNature, 1996